16,16-dimethyl prostaglandin E2

{
  "id": "MLC-T-ONC-009517",
  "term": "16,16-dimethyl prostaglandin E2",
  "field": "Oncology and biomedicine",
  "definition": "A stable derivative of prostaglandin E2 (PGE2) with potential hematopoietic activity. Administration of 16,16 dimethyl-prostaglandin E2 (dmPGE2) appears to lead to increased formation of hematopoietic stem and progenitor cells. Even though the exact mechanism of action has yet to be fully elucidated, this agent may stimulate hematopoiesis by activating the Wnt signaling pathway, which increases cellular levels of beta-catenin, a subunit of the cadherin protein complex.",
  "abbreviation": "dmPGE2",
  "synonyms": [
    "16,16-dimethylprostaglandin E2"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/1616-dimethyl-prostaglandin-e2/"
}